GO
Loading...

Enter multiple symbols separated by commas

Neurocrine Biosciences Inc

More

  • *Brent crude hovers near $51 a barrel. NEW YORK, Jan 8- U.S. stocks climbed on Thursday, a day after equities snapped a five-day losing skid, on expectations for continued acceleration in the U.S. economy and more aggressive action by the European Central Bank. There is a Fed that is going to be patient and pretty transparent on when they are going to raise rates and an...

  • Jan 8- An experimental drug being developed by AbbVie Inc and Neurocrine Biosciences Inc successfully reduced symptoms of endometriosis in pre-menopausal women in the first of two late-stage studies. Neurocrine's stock soared 24 percent to $27.20 in premarket trading on Thursday, while AbbVie's shares were up 1.7 percent at $68.10. After six months of...

  • Jan 8- An experimental drug being developed by AbbVie Inc and Neurocrine Biosciences Inc successfully reduced symptoms of endometriosis in premenopausal women in the first of two late-stage studies. Endometriosis occurs when the lining of the uterus grows outside of the womb, leading to chronic pelvic pain. After six months of treatment, both doses of the...

  • Lightning Round: Sprint, Annaly Capital & More Wednesday, 29 May 2013 | 6:43 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • San Diego: The New Silicon Valley of Biotechnology? Thursday, 11 Apr 2013 | 1:07 PM ET
    San Diego

    San Diego is at ease with sandy beaches, and biotechnology.

  • After-Hours Buzz: MAR, AMAT, NUVA & More Wednesday, 3 Oct 2012 | 4:45 PM ET
    market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after the bell Wednesday.

  • Stocks Close Mixed As Dow Rebounds Thursday, 13 Dec 2007 | 3:59 PM ET

    Stocks closed mixed as worries about a weakening economy and credit crunch continued to rattle the markets.